首页 > 最新文献

Clinical Hypertension最新文献

英文 中文
Spousal concordance of ideal cardiovascular health metrics: findings from the 2014-2019 Korea National Health and Nutrition Examination Survey. 理想心血管健康指标的配偶一致性:2014-2019年韩国国家健康与营养检查调查结果
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-12-15 DOI: 10.1186/s40885-022-00224-3
Manh Thang Hoang, Hokyou Lee, Hyeon Chang Kim

Backgrounds: We aimed to investigate whether a spouse's cardiovascular health (CVH) metrics status affects the other spouse's ideal CVH using a Korea nationwide representative survey.

Methods: We used the health data of 6,030 married couples who participated in the Korea National Health and Nutrition Examination Survey from 2014 to 2019. The CVH was defined using seven metrics: smoking status, blood pressure, body mass index, total cholesterol, fasting blood glucose, physical activity, and diet, following the American Heart Association guidelines and modifications for body mass index cutoffs and diet quality. The CVH score was calculated on a scale ranging from 0 to 7, with the ideal CVH defined as attaining ideal scores in at least five CVH metrics. Multiple logistic regression analyses were used to assess whether husband's ideal CVH was associated with his wife's odds for having ideal CVH, and vice versa.

Results: The mean CVH scores were 3.2 and 4.0 for husband and wife, respectively. After fully adjusting for age and education of both partners and household income, husbands had 1.49 times (95% confidence interval [CI], 1.27-1.69) higher odds of achieving ideal CVH if their wives had also achieved ideal CVH. Meanwhile, wives whose husbands achieved ideal CVH also had 1.46 times (95% CI, 1.27-1.69) higher odds of achieving ideal CVH. Nonsmoking (57.17%), ideal fasting blood glucose level (34.93%), and ideal diet intake (24.18%) were the most concordant CVH metrics among spouses.

Conclusions: Our study found a significant spousal concordance of ideal CVH in Korean married couples. This finding supports the use of a couple-based interventional strategy targeted to promote CVH.

背景:我们的目的是调查配偶的心血管健康(CVH)指标状态是否影响配偶的理想CVH使用韩国全国代表性调查。方法:利用2014 - 2019年参加韩国国家健康与营养检查调查的6030对已婚夫妇的健康数据。CVH的定义使用七个指标:吸烟状况、血压、体重指数、总胆固醇、空腹血糖、身体活动和饮食,遵循美国心脏协会指南和对体重指数临界值和饮食质量的修改。CVH评分在0到7的范围内计算,理想CVH定义为在至少五个CVH指标中达到理想分数。使用多元逻辑回归分析来评估丈夫的理想CVH是否与妻子的理想CVH相关,反之亦然。结果:夫妻CVH平均评分分别为3.2分和4.0分。在充分调整了配偶双方的年龄、受教育程度和家庭收入后,如果妻子也达到理想CVH,丈夫达到理想CVH的几率要高出1.49倍(95%置信区间[CI], 1.27-1.69)。与此同时,丈夫达到理想CVH的妻子获得理想CVH的几率也高出1.46倍(95% CI, 1.27-1.69)。不吸烟(57.17%)、理想空腹血糖水平(34.93%)和理想饮食摄入(24.18%)是夫妻之间最一致的CVH指标。结论:我们的研究发现韩国已婚夫妇理想CVH的配偶一致性显著。这一发现支持使用以夫妻为基础的干预策略来促进CVH。
{"title":"Spousal concordance of ideal cardiovascular health metrics: findings from the 2014-2019 Korea National Health and Nutrition Examination Survey.","authors":"Manh Thang Hoang,&nbsp;Hokyou Lee,&nbsp;Hyeon Chang Kim","doi":"10.1186/s40885-022-00224-3","DOIUrl":"https://doi.org/10.1186/s40885-022-00224-3","url":null,"abstract":"<p><strong>Backgrounds: </strong>We aimed to investigate whether a spouse's cardiovascular health (CVH) metrics status affects the other spouse's ideal CVH using a Korea nationwide representative survey.</p><p><strong>Methods: </strong>We used the health data of 6,030 married couples who participated in the Korea National Health and Nutrition Examination Survey from 2014 to 2019. The CVH was defined using seven metrics: smoking status, blood pressure, body mass index, total cholesterol, fasting blood glucose, physical activity, and diet, following the American Heart Association guidelines and modifications for body mass index cutoffs and diet quality. The CVH score was calculated on a scale ranging from 0 to 7, with the ideal CVH defined as attaining ideal scores in at least five CVH metrics. Multiple logistic regression analyses were used to assess whether husband's ideal CVH was associated with his wife's odds for having ideal CVH, and vice versa.</p><p><strong>Results: </strong>The mean CVH scores were 3.2 and 4.0 for husband and wife, respectively. After fully adjusting for age and education of both partners and household income, husbands had 1.49 times (95% confidence interval [CI], 1.27-1.69) higher odds of achieving ideal CVH if their wives had also achieved ideal CVH. Meanwhile, wives whose husbands achieved ideal CVH also had 1.46 times (95% CI, 1.27-1.69) higher odds of achieving ideal CVH. Nonsmoking (57.17%), ideal fasting blood glucose level (34.93%), and ideal diet intake (24.18%) were the most concordant CVH metrics among spouses.</p><p><strong>Conclusions: </strong>Our study found a significant spousal concordance of ideal CVH in Korean married couples. This finding supports the use of a couple-based interventional strategy targeted to promote CVH.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"28 1","pages":"41"},"PeriodicalIF":4.2,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10367212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of the magnitude of the difference in blood pressure between office and ambulatory measurements with blood pressure variability in untreated individuals. 办公室和门诊测量血压差异的大小与未治疗个体血压变异性的关系。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-12-15 DOI: 10.1186/s40885-022-00220-7
Yea Je Lee, Moo-Yong Rhee, Je Sang Kim, Ungjeong Do, Ji-Hyun Kim, Byong-Kyu Kim, Hae-Young Kim

Objectives: We evaluated the association between cardiovascular risk factors and the magnitude of the difference in systolic blood pressure (SBP) between office and ambulatory measurements (masked effect) in untreated individuals without apparent hypertension-mediated organ damage (HMOD).

Methods: The inclusion criteria were 1) age ≥ 20 years, 2) blood pressure ≥ 140/90 mmHg at the outpatient clinic, and 3) not receiving antihypertensive medications. The difference between office and ambulatory SBP was calculated by subtracting the ambulatory daytime SBP from the office SBP. The association between the masked effect and SBP variability was analyzed in individuals without HMOD (no electrocardiographic left ventricular hypertrophy, spot urine albumin-to-creatinine ratio < 30 mg/g, and estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2, n = 296).

Results: Among the cardiovascular risk factors, ambulatory BP variability was significantly correlated with the SBP difference. The standard deviation (SD) and coefficient of variation (cv) of 24-h SBP exhibited a significant negative linear association with the SBP difference in univariate and multivariate analyses adjusted for age, sex, presence of diabetes, and 24-h ambulatory SBP. A significant association was observed in patients with ambulatory daytime hypertension. In the multivariate analysis, individuals with a negative SBP difference > -5 mmHg exhibited a higher SD and cv of 24-h SBP than those with a negative SBP difference ≤ -5 mmHg or a positive SBP difference.

Conclusions: The results of our study suggest that the magnitude of the negative difference in office and ambulatory SBP may be a potential risk factor, even in individuals without apparent HMOD.

Trial registration: This trial is registered with ClinicalTrials.gov ( NCT03855605 ).

目的:我们评估在没有明显高血压介导的器官损伤(HMOD)的未经治疗的个体中,心血管危险因素与办公室和门诊测量的收缩压(SBP)差异幅度(掩盖效应)之间的关系。方法:纳入标准为:1)年龄≥20岁,2)门诊血压≥140/90 mmHg, 3)未接受降压药物治疗。办公室收缩压和日间收缩压的差值是通过办公室收缩压减去日间收缩压来计算的。在没有HMOD的个体(无心电图左心室肥厚,斑点尿白蛋白与肌酐比值2,n = 296)中分析掩盖效应与收缩压变异性之间的关系。结果:在心血管危险因素中,动态血压变异性与收缩压差异显著相关。在单因素和多因素分析中,24小时收缩压的标准差(SD)和变异系数(cv)与年龄、性别、是否患有糖尿病和24小时动态收缩压的差异呈显著的负线性相关。在日间日间高血压患者中观察到显著的相关性。在多变量分析中,收缩压负差> -5 mmHg的个体的24小时收缩压SD和cv高于收缩压负差≤-5 mmHg或收缩压正差的个体。结论:我们的研究结果表明,办公室和动态收缩压的负差值可能是一个潜在的危险因素,即使在没有明显HMOD的个体中也是如此。试验注册:该试验已在ClinicalTrials.gov注册(NCT03855605)。
{"title":"Association of the magnitude of the difference in blood pressure between office and ambulatory measurements with blood pressure variability in untreated individuals.","authors":"Yea Je Lee,&nbsp;Moo-Yong Rhee,&nbsp;Je Sang Kim,&nbsp;Ungjeong Do,&nbsp;Ji-Hyun Kim,&nbsp;Byong-Kyu Kim,&nbsp;Hae-Young Kim","doi":"10.1186/s40885-022-00220-7","DOIUrl":"https://doi.org/10.1186/s40885-022-00220-7","url":null,"abstract":"<p><strong>Objectives: </strong>We evaluated the association between cardiovascular risk factors and the magnitude of the difference in systolic blood pressure (SBP) between office and ambulatory measurements (masked effect) in untreated individuals without apparent hypertension-mediated organ damage (HMOD).</p><p><strong>Methods: </strong>The inclusion criteria were 1) age ≥ 20 years, 2) blood pressure ≥ 140/90 mmHg at the outpatient clinic, and 3) not receiving antihypertensive medications. The difference between office and ambulatory SBP was calculated by subtracting the ambulatory daytime SBP from the office SBP. The association between the masked effect and SBP variability was analyzed in individuals without HMOD (no electrocardiographic left ventricular hypertrophy, spot urine albumin-to-creatinine ratio < 30 mg/g, and estimated glomerular filtration rate ≥ 60 mL/min/1.73 m<sup>2</sup>, n = 296).</p><p><strong>Results: </strong>Among the cardiovascular risk factors, ambulatory BP variability was significantly correlated with the SBP difference. The standard deviation (SD) and coefficient of variation (cv) of 24-h SBP exhibited a significant negative linear association with the SBP difference in univariate and multivariate analyses adjusted for age, sex, presence of diabetes, and 24-h ambulatory SBP. A significant association was observed in patients with ambulatory daytime hypertension. In the multivariate analysis, individuals with a negative SBP difference > -5 mmHg exhibited a higher SD and cv of 24-h SBP than those with a negative SBP difference ≤ -5 mmHg or a positive SBP difference.</p><p><strong>Conclusions: </strong>The results of our study suggest that the magnitude of the negative difference in office and ambulatory SBP may be a potential risk factor, even in individuals without apparent HMOD.</p><p><strong>Trial registration: </strong>This trial is registered with ClinicalTrials.gov ( NCT03855605 ).</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"28 1","pages":"36"},"PeriodicalIF":4.2,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10360730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of brain natriuretic peptide and copeptin as correlates of blood pressure in chronic hypertensive pregnant women. 评估脑钠肽和 copeptin 与慢性高血压孕妇血压的相关性。
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-12-15 DOI: 10.1186/s40885-022-00221-6
Chika J Okwor, Kayode S Adedapo, Oluwasomidoyin O Bello, Ijeoma A Meka, Chukwuemeka V Okwor, Chukwuemelie Z Uche, Chiebonam E Nwajiobi, Uloaku A Nto-Ezimah, Chisom E Uchechukwu, Ekene J Arum

Background: Hypertensive disorders of pregnancy including preexisting (or chronic) hypertension are the most common complication encountered during pregnancy that contribute significantly to maternal and perinatal morbidity and mortality. Brain natriuretic peptide (BNP) and copeptin have been investigated as biomarkers in various hypertensive disorders, but studies of their clinical value in chronic hypertensive pregnant women are sparce. This study aimed to assess the levels of BNP and copeptin in chronic hypertensive pregnant women and investigate their correlation with blood pressure (BP) in chronic hypertensive pregnant women in South Western Nigeria.

Methods: One hundred and sixty consenting pregnant women in their third trimester of pregnancy, grouped into those with chronic hypertension (n = 80) and normotensive (n = 80), were recruited for this cross-sectional study. Age and clinical characteristics were obtained, and blood was aseptically drawn for BNP and copeptin measurement using enzyme-linked immunosorbent assay. Data was analyzed with IBM SPSS ver. 20.0. Data was analyzed using Student t-test, chi-square, and Pearson correlation test as appropriate. Statistical significance was set at P < 0.05.

Results: The mean systolic BP (SBP) and diastolic BP (DBP) were significantly higher in pregnant women with chronic hypertension (158.30 ± 3.51 and 105.08 ± 2.47 mmHg, respectively) compared with normotensive pregnant women (100.72 ± 3.02 and 70.29 ± 1.96 mmHg, respectively). The mean levels of BNP and copeptin were higher in pregnant women with chronic hypertension (57.26 ± 3.65 pg/mL and 12.44 ± 1.02 pmol/L, respectively) compared with normotensive pregnant women (49.85 ± 2.44 pg/mL and 10.25 ± 1.50 pmol/L, respectively) though not statistically significant. Correlations observed between SBP and DBP with levels of BNP (r = 0.204, P = 0.200; r = 0.142, P = 0.478) and copeptin (r = - 0.058, P = 0.288; r = 0.045, P = 0.907) were not statistically significant.

Conclusions: There was no association between BP and the levels of BNP and copeptin in pregnant women with chronic hypertension who were already on antihypertensive treatment, with the implication that antihypertensive treatment may modulate BNP and copeptin release despite significantly elevated BP levels.

背景:妊娠期高血压疾病(包括原有(或慢性)高血压)是妊娠期最常见的并发症,对孕产妇和围产儿的发病率和死亡率有重大影响。脑钠肽 (BNP) 和 copeptin 已被研究作为各种高血压疾病的生物标志物,但对它们在慢性高血压孕妇中的临床价值的研究却很少。本研究旨在评估尼日利亚西南部慢性高血压孕妇的 BNP 和 copeptin 水平,并研究它们与慢性高血压孕妇血压(BP)的相关性:这项横断面研究招募了 160 名同意参加的怀孕三个月的孕妇,分为慢性高血压孕妇(80 人)和正常血压孕妇(80 人)。研究人员采集了孕妇的年龄和临床特征,并无菌抽血,使用酶联免疫吸附法测定 BNP 和 copeptin。数据分析采用 IBM SPSS ver.20.0.数据分析酌情采用学生 t 检验、卡方检验和皮尔逊相关检验。统计显著性设定为 P 结果:与血压正常的孕妇(分别为 100.72 ± 3.02 和 70.29 ± 1.96 mmHg)相比,慢性高血压孕妇的平均收缩压(SBP)和舒张压(DBP)明显升高(分别为 158.30 ± 3.51 和 105.08 ± 2.47 mmHg)。与血压正常的孕妇(分别为 49.85 ± 2.44 pg/mL 和 10.25 ± 1.50 pmol/L)相比,慢性高血压孕妇的 BNP 和 copeptin 平均水平更高(分别为 57.26 ± 3.65 pg/mL 和 12.44 ± 1.02 pmol/L),但无统计学意义。观察到的 SBP 和 DBP 与 BNP(r = 0.204,P = 0.200;r = 0.142,P = 0.478)和 copeptin(r = - 0.058,P = 0.288;r = 0.045,P = 0.907)水平之间的相关性无统计学意义:结论:在已接受降压治疗的慢性高血压孕妇中,血压与 BNP 和 copeptin 水平之间没有关联,这意味着尽管血压水平显著升高,降压治疗仍可调节 BNP 和 copeptin 的释放。
{"title":"Assessment of brain natriuretic peptide and copeptin as correlates of blood pressure in chronic hypertensive pregnant women.","authors":"Chika J Okwor, Kayode S Adedapo, Oluwasomidoyin O Bello, Ijeoma A Meka, Chukwuemeka V Okwor, Chukwuemelie Z Uche, Chiebonam E Nwajiobi, Uloaku A Nto-Ezimah, Chisom E Uchechukwu, Ekene J Arum","doi":"10.1186/s40885-022-00221-6","DOIUrl":"10.1186/s40885-022-00221-6","url":null,"abstract":"<p><strong>Background: </strong>Hypertensive disorders of pregnancy including preexisting (or chronic) hypertension are the most common complication encountered during pregnancy that contribute significantly to maternal and perinatal morbidity and mortality. Brain natriuretic peptide (BNP) and copeptin have been investigated as biomarkers in various hypertensive disorders, but studies of their clinical value in chronic hypertensive pregnant women are sparce. This study aimed to assess the levels of BNP and copeptin in chronic hypertensive pregnant women and investigate their correlation with blood pressure (BP) in chronic hypertensive pregnant women in South Western Nigeria.</p><p><strong>Methods: </strong>One hundred and sixty consenting pregnant women in their third trimester of pregnancy, grouped into those with chronic hypertension (n = 80) and normotensive (n = 80), were recruited for this cross-sectional study. Age and clinical characteristics were obtained, and blood was aseptically drawn for BNP and copeptin measurement using enzyme-linked immunosorbent assay. Data was analyzed with IBM SPSS ver. 20.0. Data was analyzed using Student t-test, chi-square, and Pearson correlation test as appropriate. Statistical significance was set at P < 0.05.</p><p><strong>Results: </strong>The mean systolic BP (SBP) and diastolic BP (DBP) were significantly higher in pregnant women with chronic hypertension (158.30 ± 3.51 and 105.08 ± 2.47 mmHg, respectively) compared with normotensive pregnant women (100.72 ± 3.02 and 70.29 ± 1.96 mmHg, respectively). The mean levels of BNP and copeptin were higher in pregnant women with chronic hypertension (57.26 ± 3.65 pg/mL and 12.44 ± 1.02 pmol/L, respectively) compared with normotensive pregnant women (49.85 ± 2.44 pg/mL and 10.25 ± 1.50 pmol/L, respectively) though not statistically significant. Correlations observed between SBP and DBP with levels of BNP (r = 0.204, P = 0.200; r = 0.142, P = 0.478) and copeptin (r = - 0.058, P = 0.288; r = 0.045, P = 0.907) were not statistically significant.</p><p><strong>Conclusions: </strong>There was no association between BP and the levels of BNP and copeptin in pregnant women with chronic hypertension who were already on antihypertensive treatment, with the implication that antihypertensive treatment may modulate BNP and copeptin release despite significantly elevated BP levels.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"28 1","pages":"37"},"PeriodicalIF":2.6,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10712250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate pressor response to oral salt and its assessment in the clinic: a time series clinical trial. 口服盐的即刻降压反应及其临床评估:一项时间序列临床试验。
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-09-15 DOI: 10.1186/s40885-022-00209-2
Sepiso K Masenga, Leta Pilic, Benson M Hamooya, Selestine Nzala, Douglas C Heimburger, Wilbroad Mutale, John R Koethe, Annet Kirabo, Sody M Munsaka, Fernando Elijovich

Background: High blood pressure (BP) is associated with high-salt consumption especially in sub-Saharan Africa. Although the pressor effect of salt is viewed as a chronic effect, some studies suggest that a salty meal may increase BP immediately in some individuals, and that this effect may cause endothelial dysfunction. Therefore, the aim of our research was to study the immediate pressor response to oral salt (IPROS) and its determinants, with the expectation that a simple methodology may be devised to diagnose it in the clinic or in low-resource environments.

Methods: We conducted a time series trial at Livingstone Central Hospital. We present data in 127 normotensive participants who ingested 2 g of sodium chloride; their BP was monitored for 120 minutes in intervals of 10 minutes. Sociodemographic and clinical data were collected. Descriptive and inferential statistics were used for analyses of data.

Results: Median age was 30 years (interquartile range, 22-46 years) and 52% were female patients. An increase of ≥10 mmHg in mean arterial pressure (MAP), considered a clinically significant IPROS, was present in 62% of participants. Systolic BP 30 minutes after the salt load was a significant predictor of IPROS, avoiding the need to calculate MAP in the clinic setting.

Conclusions: We confirm the presence of an IPROS in a high proportion (62%) of otherwise normotensive participants. The average time course for this response was 30 minutes and its duration was sustained for the 120-minutes period of study in most of the participants. Prediction of IPROS by ∆SBP (change in systolic blood pressure) at 30 minutes allows for easy assessment of possible responder status in the clinic. Our data indicate that the IPROS to oral salt-loads in the range currently consumed by the Western world and African populations in single meals may increase the 24-hour BP load, which is a risk factor for hypertension and target organ damage. The relevance of our findings indicates the need to include dietary sodium assessment in the diagnosis, prevention, and management of high BP.

背景:高血压(BP)与高盐摄入有关,特别是在撒哈拉以南非洲地区。尽管盐的降压作用被认为是一种慢性效应,但一些研究表明,在某些个体中,盐餐可能会立即升高血压,这种效应可能导致内皮功能障碍。因此,我们的研究目的是研究口服盐(IPROS)的即刻升压反应及其决定因素,期望在临床或低资源环境中设计一种简单的方法来诊断它。方法:在利文斯通中心医院进行时间序列试验。我们提供了127名摄入2g氯化钠的正常受试者的数据;他们的血压每隔10分钟监测120分钟。收集社会人口学和临床数据。数据分析采用描述性统计和推理统计。结果:中位年龄为30岁(四分位数范围22 ~ 46岁),女性患者占52%。62%的参与者平均动脉压(MAP)升高≥10 mmHg,被认为是临床显著的IPROS。盐负荷后30分钟的收缩压是IPROS的重要预测因子,避免了在临床环境中计算MAP的需要。结论:我们证实,在其他血压正常的参与者中,高比例(62%)存在IPROS。这种反应的平均时间为30分钟,大多数参与者的反应持续时间为120分钟。通过30分钟收缩压变化(∆SBP)预测IPROS,可以方便地评估临床可能的应答状态。我们的数据表明,目前西方世界和非洲人群单餐摄入的IPROS对口服盐负荷的影响可能会增加24小时血压负荷,这是高血压和靶器官损伤的一个危险因素。我们研究结果的相关性表明,有必要将饮食钠评估纳入高血压的诊断、预防和管理中。
{"title":"Immediate pressor response to oral salt and its assessment in the clinic: a time series clinical trial.","authors":"Sepiso K Masenga,&nbsp;Leta Pilic,&nbsp;Benson M Hamooya,&nbsp;Selestine Nzala,&nbsp;Douglas C Heimburger,&nbsp;Wilbroad Mutale,&nbsp;John R Koethe,&nbsp;Annet Kirabo,&nbsp;Sody M Munsaka,&nbsp;Fernando Elijovich","doi":"10.1186/s40885-022-00209-2","DOIUrl":"https://doi.org/10.1186/s40885-022-00209-2","url":null,"abstract":"<p><strong>Background: </strong>High blood pressure (BP) is associated with high-salt consumption especially in sub-Saharan Africa. Although the pressor effect of salt is viewed as a chronic effect, some studies suggest that a salty meal may increase BP immediately in some individuals, and that this effect may cause endothelial dysfunction. Therefore, the aim of our research was to study the immediate pressor response to oral salt (IPROS) and its determinants, with the expectation that a simple methodology may be devised to diagnose it in the clinic or in low-resource environments.</p><p><strong>Methods: </strong>We conducted a time series trial at Livingstone Central Hospital. We present data in 127 normotensive participants who ingested 2 g of sodium chloride; their BP was monitored for 120 minutes in intervals of 10 minutes. Sociodemographic and clinical data were collected. Descriptive and inferential statistics were used for analyses of data.</p><p><strong>Results: </strong>Median age was 30 years (interquartile range, 22-46 years) and 52% were female patients. An increase of ≥10 mmHg in mean arterial pressure (MAP), considered a clinically significant IPROS, was present in 62% of participants. Systolic BP 30 minutes after the salt load was a significant predictor of IPROS, avoiding the need to calculate MAP in the clinic setting.</p><p><strong>Conclusions: </strong>We confirm the presence of an IPROS in a high proportion (62%) of otherwise normotensive participants. The average time course for this response was 30 minutes and its duration was sustained for the 120-minutes period of study in most of the participants. Prediction of IPROS by ∆SBP (change in systolic blood pressure) at 30 minutes allows for easy assessment of possible responder status in the clinic. Our data indicate that the IPROS to oral salt-loads in the range currently consumed by the Western world and African populations in single meals may increase the 24-hour BP load, which is a risk factor for hypertension and target organ damage. The relevance of our findings indicates the need to include dietary sodium assessment in the diagnosis, prevention, and management of high BP.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"28 1","pages":"25"},"PeriodicalIF":4.2,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10603974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Association between ethnicity and hypertension in Northern Colombia in 2015 2015年哥伦比亚北部种族与高血压的关系
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-06-15 DOI: 10.1186/s40885-022-00203-8
Drew H. Smith, Jaskaran Grewal, Saba Mehboob, Shiva Mohan, L. Pombo, Pura Rodriguez, J. González, J. Zevallos, N. Barengo
{"title":"Association between ethnicity and hypertension in Northern Colombia in 2015","authors":"Drew H. Smith, Jaskaran Grewal, Saba Mehboob, Shiva Mohan, L. Pombo, Pura Rodriguez, J. González, J. Zevallos, N. Barengo","doi":"10.1186/s40885-022-00203-8","DOIUrl":"https://doi.org/10.1186/s40885-022-00203-8","url":null,"abstract":"","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":" ","pages":""},"PeriodicalIF":4.2,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43386615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing self-reported and measured hypertension and hypercholesterolaemia at standard and more stringent diagnostic thresholds: the cross-sectional 2010–2015 Busselton Healthy Ageing study 在标准和更严格的诊断阈值下比较自我报告和测量的高血压和高胆固醇血症:2010-2015年Busselton健康老龄化横断面研究
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-06-01 DOI: 10.1186/s40885-022-00199-1
Angela J Burvill, K. Murray, M. Knuiman, J. Hung
{"title":"Comparing self-reported and measured hypertension and hypercholesterolaemia at standard and more stringent diagnostic thresholds: the cross-sectional 2010–2015 Busselton Healthy Ageing study","authors":"Angela J Burvill, K. Murray, M. Knuiman, J. Hung","doi":"10.1186/s40885-022-00199-1","DOIUrl":"https://doi.org/10.1186/s40885-022-00199-1","url":null,"abstract":"","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":" ","pages":""},"PeriodicalIF":4.2,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41991137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review 接受靶向治疗的癌症患者高血压的风险和管理:综述
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-05-15 DOI: 10.1186/s40885-022-00197-3
Xiaolei Zhu, Shenhong Wu
{"title":"Risks and management of hypertension in cancer patients undergoing targeted therapy: a review","authors":"Xiaolei Zhu, Shenhong Wu","doi":"10.1186/s40885-022-00197-3","DOIUrl":"https://doi.org/10.1186/s40885-022-00197-3","url":null,"abstract":"","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":" ","pages":""},"PeriodicalIF":4.2,"publicationDate":"2022-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47391130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias 校正发表偏倚后循环25-羟基维生素D水平与高血压风险
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-05-15 DOI: 10.1186/s40885-022-00196-4
J. Bae
{"title":"Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias","authors":"J. Bae","doi":"10.1186/s40885-022-00196-4","DOIUrl":"https://doi.org/10.1186/s40885-022-00196-4","url":null,"abstract":"","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":" ","pages":""},"PeriodicalIF":4.2,"publicationDate":"2022-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43647936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventions in hypertension: systematic review and meta-analysis of natural and quasi-experiments. 高血压干预:自然实验和准实验的系统回顾和荟萃分析。
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-05-01 DOI: 10.1186/s40885-022-00198-2
Tong Xia, Fan Zhao, Roch A Nianogo

Background: Hypertension is an urgent public health problem. Consistent summary from natural and quasi-experiments employed to evaluate interventions that aim at preventing or controlling hypertension is lacking in the current literature. This study aims to summarize the evidence from natural and quasi-experiments that evaluated interventions used to prevent or control hypertension.

Methods: We searched PubMed, Embase and Web of Science for natural and quasi-experiments evaluating interventions used to prevent hypertension, improve blood pressure control or reduce blood pressure levels from January 2008 to November 2018. Descriptions of studies and interventions were systematically summarized, and a meta-analysis was conducted.

Results: Thirty studies were identified, and all used quasi-experimental designs including a difference-in-difference, a pre-post with a control group or a propensity score matching design. Education and counseling on lifestyle modifications such as promoting physical activity (PA), promoting a healthy diet and smoking cessation consultations could help prevent hypertension in healthy people. The use of computerized clinical practice guidelines by general practitioners, education and management of hypertension, the screening for cardiovascular disease (CVD) goals and referral could help improve hypertension control in patients with hypertension. The educating and counseling on PA and diet, the monitoring of patients' metabolic factors and chronic diseases, the combination of education on lifestyles with management of hypertension, the screening for economic risk factors, medical needs, and CVD risk factors and referral all could help reduce blood pressure. In the meta-analysis, the largest reduction in blood pressure was seen for interventions which combined education, counseling and management strategies: weighted mean difference in systolic blood pressure was - 5.34 mmHg (95% confidence interval [CI], - 7.35 to - 3.33) and in diastolic blood pressure was - 3.23 mmHg (95% CI, - 5.51 to - 0.96).

Conclusions: Interventions that used education and counseling strategies; those that used management strategies; those that used combined education, counseling and management strategies and those that used screening and referral strategies were beneficial in preventing, controlling hypertension and reducing blood pressure levels. The combination of education, counseling and management strategies appeared to be the most beneficial intervention to reduce blood pressure levels.

背景:高血压是一个紧迫的公共卫生问题:高血压是一个紧迫的公共卫生问题。目前的文献中缺乏对用于评估预防或控制高血压干预措施的自然实验和准实验的一致总结。本研究旨在总结评估用于预防或控制高血压的干预措施的自然实验和准实验证据:我们检索了PubMed、Embase和Web of Science中从2008年1月至2018年11月评估用于预防高血压、改善血压控制或降低血压水平的干预措施的自然实验和准实验。对研究和干预措施的描述进行了系统总结,并进行了荟萃分析:共确定了 30 项研究,所有研究都采用了准实验设计,包括差异设计、带有对照组的预后设计或倾向得分匹配设计。关于改变生活方式的教育和咨询,如促进体育锻炼(PA)、提倡健康饮食和戒烟咨询,有助于预防健康人群的高血压。全科医生使用计算机化临床实践指南、高血压的教育和管理、心血管疾病(CVD)目标筛查和转诊有助于改善高血压患者的高血压控制。PA 和饮食方面的教育和咨询、对患者代谢因素和慢性疾病的监测、生活方式教育与高血压管理的结合、经济风险因素、医疗需求和心血管疾病风险因素的筛查以及转诊都有助于降低血压。在荟萃分析中,结合了教育、咨询和管理策略的干预措施的血压降幅最大:收缩压的加权平均差异为-5.34毫米汞柱(95%置信区间[CI],-7.35至-3.33),舒张压的加权平均差异为-3.23毫米汞柱(95%置信区间,-5.51至-0.96):采用教育和咨询策略;采用管理策略;采用教育、咨询和管理相结合的策略以及采用筛查和转诊策略的干预措施都有利于预防、控制高血压和降低血压水平。教育、咨询和管理相结合的策略似乎是对降低血压水平最有益的干预措施。
{"title":"Interventions in hypertension: systematic review and meta-analysis of natural and quasi-experiments.","authors":"Tong Xia, Fan Zhao, Roch A Nianogo","doi":"10.1186/s40885-022-00198-2","DOIUrl":"10.1186/s40885-022-00198-2","url":null,"abstract":"<p><strong>Background: </strong>Hypertension is an urgent public health problem. Consistent summary from natural and quasi-experiments employed to evaluate interventions that aim at preventing or controlling hypertension is lacking in the current literature. This study aims to summarize the evidence from natural and quasi-experiments that evaluated interventions used to prevent or control hypertension.</p><p><strong>Methods: </strong>We searched PubMed, Embase and Web of Science for natural and quasi-experiments evaluating interventions used to prevent hypertension, improve blood pressure control or reduce blood pressure levels from January 2008 to November 2018. Descriptions of studies and interventions were systematically summarized, and a meta-analysis was conducted.</p><p><strong>Results: </strong>Thirty studies were identified, and all used quasi-experimental designs including a difference-in-difference, a pre-post with a control group or a propensity score matching design. Education and counseling on lifestyle modifications such as promoting physical activity (PA), promoting a healthy diet and smoking cessation consultations could help prevent hypertension in healthy people. The use of computerized clinical practice guidelines by general practitioners, education and management of hypertension, the screening for cardiovascular disease (CVD) goals and referral could help improve hypertension control in patients with hypertension. The educating and counseling on PA and diet, the monitoring of patients' metabolic factors and chronic diseases, the combination of education on lifestyles with management of hypertension, the screening for economic risk factors, medical needs, and CVD risk factors and referral all could help reduce blood pressure. In the meta-analysis, the largest reduction in blood pressure was seen for interventions which combined education, counseling and management strategies: weighted mean difference in systolic blood pressure was - 5.34 mmHg (95% confidence interval [CI], - 7.35 to - 3.33) and in diastolic blood pressure was - 3.23 mmHg (95% CI, - 5.51 to - 0.96).</p><p><strong>Conclusions: </strong>Interventions that used education and counseling strategies; those that used management strategies; those that used combined education, counseling and management strategies and those that used screening and referral strategies were beneficial in preventing, controlling hypertension and reducing blood pressure levels. The combination of education, counseling and management strategies appeared to be the most beneficial intervention to reduce blood pressure levels.</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"28 1","pages":"13"},"PeriodicalIF":2.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057066/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10240181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of adherence measured by self-reported pill count with achieved blood pressure level in hypertension patients: a cross-sectional study 一项横断面研究:高血压患者自我报告服药数与血压水平的相关性
IF 4.2 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-04-15 DOI: 10.1186/s40885-022-00195-5
Iin Ernawati, Eziah Ika Lubada, Ria Lusiyani, R. A. Prasetya
{"title":"Association of adherence measured by self-reported pill count with achieved blood pressure level in hypertension patients: a cross-sectional study","authors":"Iin Ernawati, Eziah Ika Lubada, Ria Lusiyani, R. A. Prasetya","doi":"10.1186/s40885-022-00195-5","DOIUrl":"https://doi.org/10.1186/s40885-022-00195-5","url":null,"abstract":"","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":" ","pages":""},"PeriodicalIF":4.2,"publicationDate":"2022-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44766446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Clinical Hypertension
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1